Efficacy of preclinical GSK3β and clinical CDK4/6 inhibitors against acquired chemoresistance in pancreatic cancer: preliminary observation
Efficacy of preclinical GSK3β and clinical CDK4/6 inhibitors against acquired chemoresistance in pancreatic cancer: preliminary observation
复制标题
临床前 GSK3β 和临床 CDK4/6 抑制剂对胰腺癌获得性化疗耐药的疗效：初步观察
DOI：
--
复制
发表时间：
2022
期刊：
影响因子：
--
通讯作者：
Toshinari Minamoto
中科院分区：
文献类型：
--
作者：
Masahiro Uehara;Takahiro Domoto;Shin-ichi Horike;Francis Giles;Ludimila Cavalcante;Chiaki Takahashi;Toshinari Minamoto
